The Role of Telehealth in Pediatric and Adult Infections: Best Practices and Care Considerations for Influenza

Released On
June 18, 2021

Expires On
June 18, 2022

Media Type
Internet

Completion Time
60 minutes

 

 

Scroll to the Bottom of this Information to Begin this Course

This educational activity is jointly provided by the Postgraduate Institute for Medicine and Spire Learning.

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity has been designed to meet the educational needs of physicians, nurse practitioners, physician assistants, and other members of the health care team who care for patients with influenza in the primary care setting.

Program Overview

Are you prepared to manage influenza in the era of COVID-19? Listen to Dr Paul G. Auwaerter’s and Dr Javeed Siddiqui’s discussion on the challenges of influenza management in the midst of the COVID-19 pandemic. Explore solutions to your questions about best practices to assess influenza via telehealth, strategies for influenza prophylaxis, and selecting antivirals for children, adolescents, and adults, including patients at high risk of influenza complications.

Learning Objectives

Upon completion of this activity, learners should be better able to:

  • SUMMARIZE best practices to conduct visits and assess for influenza via telehealth in the primary care setting
  • RECOMMEND influenza prevention strategies
  • IMPLEMENT proper antiviral treatment of influenza for children and adults, including patients at high risk of complications of influenza

 

Faculty

Paul G. Auwaerter, MD, MBA, FIDSA

Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Javeed Siddiqui, MD, MPH

Infectious Diseases
Chief Medical Officer
TeleMed2U
Roseville, CA

Q&A is moderated by Chris Washburn, PhD, Spire Learning

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Spire Learning. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

 

Credit Designation

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Designated for 0.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Paul G. Auwaerter, MD, MBA, FIDSA (Activity Co-Chair)
Ownership Interest: Johnson & Johnson

Javeed Siddiqui, MD, MPH (Activity Co-Chair)
Consulting Fees: AbbVie Inc; Cumberland Pharmaceuticals; Merck & Co Inc

Planners and Managers
The PIM planners and managers have nothing to disclose. The Spire Learning planners and managers have nothing to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Complete the preassessment at the start of the activity.
  3. Participate in the online activity.
  4. Complete the postassessment/evaluation form at the conclusion of the activity.
Certificates will be emailed to the participant.

 

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

For CME questions please contact: inquiries@pimed.com

Privacy Policy

Spire Learning, LLC is committed to protecting the privacy of personal information from our participants and educational collaborators. Spire maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of personal information.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected and retained, and used by Spire Learning, LLC to continuously improve the learning experience.

Spire Learning, LLC will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Spire will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.

Copyright Information

Copyright © 2021 by Spire Learning, LLC and its Licensors. All rights reserved. No part of this publication or activity may be reproduced or transmitted in any form, by any means, without prior written permission of Spire Learning, LLC. Spire Learning, LLC and Postgraduate Institute for Medicine will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication or activity, including any claims related to the products, drugs, or services mentioned herein.

Levels of Evidence

  • Levels of evidence are provided for any patient care recommendations made during this activity.
  • Each rating is applied to a single reference in the presentation, not the entire body of evidence on the topic.

Infectious Diseases Society of America – US Public Health Service Grading System for Ranking Recommendations in Clinical Guidelines